摘要: Bitcoin apparently did not like all the fanfare over good results in a COVID-19 vaccine trial.

 


COVID-19 vaccine trials

▲圖片標題(來源:cointelegraph.com)

Bitcoin (BTC) fell sharply in price this morning as pharmaceutical company Pfizer, in collaboration with biotech company BioNTech, announced a breakthrough in its COVID-19 vaccine.

Bitcoin fell approximately $1,000, over 6%, between 12:00 pm and 3:00 pm UTC today on the vaccine news, from $15,800 down to a daily low near $14,815, based on TradingView data. Crypto's pioneer asset bounced slightly by the time of publication, sitting near $14,908.

Earlier this morning, Pfizer publicized a statement claiming its COVID-19 vaccine has shown to be roughly 90% effective. The company said its numbers come after testing 43,538 subjects. The vaccine, however, still awaits final approval from the United States Food and Drug Administration:

Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November

Bolstering Bitcoin's narrative as a hedge or noncorrelated asset, traditional financial markets rose as various media outlets covered the COVID-19 vaccine news. The S&P 500 bolted up almost 4% in price at market open this morning. Meanwhile, gold, another store-of-value asset, has fallen more than 5% over the last several hours, suffering continued carnage as of publication time.

詳見全文: cointelegraph.com

若喜歡本文,請關注我們的臉書 Please Like our Facebook Page:    Big Data In Finance

 


留下你的回應

以訪客張貼回應

0
  • 找不到回應

Popular Tags